-

$undefined

N/A

(N/A)

Addex Therapeutics NASDAQ:ADXN

Location: Chemin des Mines, 9, Geneve, 1202, Switzerland | Website: https://www.addextherapeutics.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

714.5M

Cash

3.349M

Avg Qtr Burn

-1.493M

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

1.41%

Qtr Updated

09/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Dipraglurant (mGlu5 NAM) Details Levodopa-induced dyskinesia associated with Parkinson’s disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Dystonia (Blepharospasm)	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ADX71149 (JNJ-40411813) (mGlu2 PAM) Details Epilepsy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.